Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Newborn screening for 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, has been performed routinely in the United States and other countries for over 20 years. Screening provides the opportunity for early detection and treatment of patients with 21OHD, preve...
Saved in:
Main Authors: | Patrice K. Held (Author), Ian M. Bird (Author), Natasha L. Heather (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wisconsin's Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
by: Eric R. Bialk, et al.
Published: (2019) -
Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
by: Mark R. de Hora, et al.
Published: (2022) -
Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
by: Sari Edelman, et al.
Published: (2020) -
A three-year follow-up of congenital adrenal hyperplasia newborn screening
by: Isabela L. Pezzuti, et al.
Published: (2014) -
A three-year follow-up of congenital adrenal hyperplasia newborn screening
by: Isabela L. Pezzuti, et al.
Published: (2014)